Livzon Pharmaceutical Group Inc. (HKG:1513)
34.62
+0.60 (1.76%)
Sep 30, 2025, 4:08 PM HKT
HKG:1513 Market Cap
HKG:1513 has a market cap or net worth of 35.15 billion as of September 30, 2025. Its market cap has increased by 10.10% in one year.
Market Cap
35.15B
Enterprise Value
28.64B
Revenue
12.93B
Ranking
n/a
PE Ratio
14.78
Stock Price
34.62
Market Cap Chart
Since July 14, 1997, HKG:1513's market cap has increased from 365.70M to 35.15B, an increase of 9,512.32%. That is a compound annual growth rate of 17.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 35.14B | 7.56% |
Dec 31, 2024 | 32.67B | 4.83% |
Dec 29, 2023 | 31.17B | 0.42% |
Dec 30, 2022 | 31.04B | -21.73% |
Dec 31, 2021 | 39.66B | 0.71% |
Dec 31, 2020 | 39.38B | 27.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 285.15B |
Hansoh Pharmaceutical Group Company | 214.55B |
JD Health International | 214.18B |
WuXi Biologics | 160.93B |
Innovent Biologics | 160.31B |
Sino Biopharmaceutical | 144.09B |
Akeso | 124.26B |
Sichuan Kelun-Biotech Biopharmaceutical | 115.57B |